| 000 | 01551 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513094346.0 | ||
| 264 | 0 | _c19961029 | |
| 008 | 199610s 0 0 eng d | ||
| 022 | _a0165-1781 | ||
| 024 | 7 |
_a10.1016/0165-1781(96)02989-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMüller, E E | |
| 245 | 0 | 0 |
_aAspects of the neuroendocrine control of somatotropic function in calorically restricted dogs and patients with eating disorders: studies with cholinergic drugs. _h[electronic resource] |
| 260 |
_bPsychiatry research _cApr 1996 |
||
| 300 |
_a51-63 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnorexia Nervosa _xphysiopathology |
| 650 | 0 | 4 | _aArginine |
| 650 | 0 | 4 |
_aCholinergic Fibers _xphysiology |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aEnergy Intake _xphysiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFood Deprivation _xphysiology |
| 650 | 0 | 4 |
_aGrowth Hormone _xphysiology |
| 650 | 0 | 4 |
_aGrowth Hormone-Releasing Hormone _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMuscarinic Antagonists |
| 650 | 0 | 4 |
_aNeurosecretory Systems _xphysiopathology |
| 650 | 0 | 4 | _aParasympathomimetics |
| 650 | 0 | 4 | _aPirenzepine |
| 650 | 0 | 4 | _aPyridostigmine Bromide |
| 650 | 0 | 4 |
_aReceptors, Somatostatin _xphysiology |
| 700 | 1 | _aRolla, M | |
| 773 | 0 |
_tPsychiatry research _gvol. 62 _gno. 1 _gp. 51-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0165-1781(96)02989-7 _zAvailable from publisher's website |
| 999 |
_c8736174 _d8736174 |
||